261 related articles for article (PubMed ID: 2537412)
1. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
Schoemaker H; Langer SZ
J Pharmacol Exp Ther; 1989 Feb; 248(2):710-5. PubMed ID: 2537412
[TBL] [Abstract][Full Text] [Related]
2. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
Boles RG; Yamamura HI; Schoemaker H; Roeske WR
J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel receptor binding studies for diltiazem and its major metabolites: functional correlation to inhibition of portal vein myogenic activity.
Schoemaker H; Hicks PE; Langer SZ
J Cardiovasc Pharmacol; 1987 Feb; 9(2):173-80. PubMed ID: 2435995
[TBL] [Abstract][Full Text] [Related]
4. Potential-dependent allosteric modulation of 1,4-dihydropyridine binding by d-(cis)-diltiazem and (+/-)-verapamil in living cardiac cells.
Porzig H; Becker C
Mol Pharmacol; 1988 Aug; 34(2):172-9. PubMed ID: 2457793
[TBL] [Abstract][Full Text] [Related]
5. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
Messing RO; Carpenter CL; Greenberg DA
J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
[TBL] [Abstract][Full Text] [Related]
7. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
Bolger GT; Marcus KA; Daly JW; Skolnick P
J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
[TBL] [Abstract][Full Text] [Related]
8. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
Lee HR; Jaros JA; Roeske WR; Wiech NL; Ursillo R; Yamamura HI
J Pharmacol Exp Ther; 1985 Jun; 233(3):611-6. PubMed ID: 3159884
[TBL] [Abstract][Full Text] [Related]
9. Polyamines allosterically modulate [3H]nitrendipine binding to the voltage-sensitive calcium channel in rat brain.
Schoemaker H
Eur J Pharmacol; 1992 Feb; 225(2):167-9. PubMed ID: 1312941
[TBL] [Abstract][Full Text] [Related]
10. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
Hagiwara M; Adachi-Akahane S; Nagao T
J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 3H-nitrendipine binding in rat aortic and cerebral cortex membranes by the new dihydropyridine calcium antagonist benidipine hydrochloride.
Ishii A
Arzneimittelforschung; 1989 Dec; 39(12):1546-50. PubMed ID: 2624603
[TBL] [Abstract][Full Text] [Related]
12. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
13. [3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex.
Schoemaker H; Langer SZ
Eur J Pharmacol; 1985 May; 111(2):273-7. PubMed ID: 2410283
[TBL] [Abstract][Full Text] [Related]
14. [3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranes.
Sarmiento JG; Shrikhande AV; Janis RA; Triggle DJ
J Pharmacol Exp Ther; 1987 Apr; 241(1):140-6. PubMed ID: 2437286
[TBL] [Abstract][Full Text] [Related]
15. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.
Nokin P; Clinet M; Polster P; Beaufort P; Meysmans L; Gougat J; Chatelain P
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):31-6. PubMed ID: 2542806
[TBL] [Abstract][Full Text] [Related]
16. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
17. Binding of [3H]-nitrendipine and [3H]-diltiazem to rat myocardial sarcolemma.
Miwa N; Kanaide H; Nishimura J; Nakamura M
Arzneimittelforschung; 1986 Jul; 36(7):1059-62. PubMed ID: 3021180
[TBL] [Abstract][Full Text] [Related]
18. Calcium antagonist properties of diclofurime isomers. II. Molecular aspects: allosteric interactions with dihydropyridine recognition sites.
Mir AK; Spedding M
J Cardiovasc Pharmacol; 1987 Apr; 9(4):469-77. PubMed ID: 2438510
[TBL] [Abstract][Full Text] [Related]
19. Binding characteristics of a new 1,5-benzothiazepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes.
Suzuki T; Kurosawa H; Naito K; Otsuka M; Ohashi M; Takaiti O
Eur J Pharmacol; 1991 Mar; 194(2-3):195-200. PubMed ID: 2060600
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of [3H]nitrendipine binding sites in rat spinal cord.
Gandhi VC; Jones DJ
J Pharmacol Exp Ther; 1988 Nov; 247(2):473-80. PubMed ID: 2460614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
